Save your place

Sign in to WhoBought

Please try again later.

Y-mAbs Therapeutics, Inc. (YMAB) institutional ownership

Market cap$205M SectorHealthcare
Funds holding · Q4 2025
3
reported YMAB position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2025
Activity unavailable N/A
0 buyers · 3 sellers

Y-mAbs Therapeutics, Inc. (YMAB) price and institutional activity

Dates

Q4 2025

$0 bought by 0 investors
$0 sold by 3 investors
Barclays PLCBrooklyn Investment Group +1 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Y-mAbs Therapeutics, Inc. (YMAB) institutional activity · 3

Investor Type Est. change Change Δ Own Date
Barclays PLC · Exited
Change −69K Δ Own −100.0% Date Q4 2025
Barclays PLC Exited· Q4 2025 −69K −100.0% Q4 2025
Brooklyn Investment Group · Exited
Change −16K Δ Own −100.0% Date Q4 2025
Brooklyn Investment Group Exited· Q4 2025 −16K −100.0% Q4 2025
Ifp Advisors, Inc · Exited
Change −332 Δ Own −100.0% Date Q4 2025
Ifp Advisors, Inc Exited· Q4 2025 −332 −100.0% Q4 2025
Data through Q4 2025 · filed Mar 19, 2026
3 of 3

Famous investor activity in Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics, Inc. (YMAB) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hamill Laura · Director Other Form 4 events -$50K
Price $8.60 Qty -6K Owned 0 Trade date Sep 16, 2025 Filed date Sep 19, 2025
Hamill Laura Director Other Form 4 events $8.60 -6K -$50K 0 Sep 16, 2025 Sep 19, 2025
Hamill Laura · Director 7 operations -141K
Owned 0 Trade date Sep 16, 2025 Filed date Sep 19, 2025
Hamill Laura Director 7 operations -141K 0 Sep 16, 2025 Sep 19, 2025
Gad Thomas · Director 3 operations -$3.2M
Price $8.60 Qty -373K Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Gad Thomas Director 3 operations $8.60 -373K -$3.2M 0 Sep 16, 2025 Sep 18, 2025
Gad Thomas · Director 15 operations -1.4M
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Gad Thomas Director 15 operations -1.4M 0 Sep 16, 2025 Sep 18, 2025
Wg Biotech Aps · Director, 10% Owner Other Form 4 events -$39M
Price $8.60 Qty -4.6M Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Wg Biotech Aps Director, 10% Owner Other Form 4 events $8.60 -4.6M -$39M 0 Sep 16, 2025 Sep 18, 2025
Gentilcore Douglas J. · Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -143K
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Gentilcore Douglas J. Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -143K 0 Sep 16, 2025 Sep 18, 2025
Gill David N. · Director 10 operations -171K
Price $8.60 Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Gill David N. Director 10 operations $8.60 -171K 0 Sep 16, 2025 Sep 18, 2025
Tyagi Ashu · Director Other Form 4 events -$50K
Price $8.60 Qty -6K Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Tyagi Ashu Director Other Form 4 events $8.60 -6K -$50K 0 Sep 16, 2025 Sep 18, 2025
Tyagi Ashu · Director 9 operations -173K
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Tyagi Ashu Director 9 operations -173K 0 Sep 16, 2025 Sep 18, 2025
Pfreundschuh Peter P. · Officer 5 operations -343K
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Pfreundschuh Peter P. Officer 5 operations -343K 0 Sep 16, 2025 Sep 18, 2025
Rossi Michael J. · Director, Officer Other Form 4 events -$69K
Price $8.60 Qty -8K Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Rossi Michael J. Director, Officer Other Form 4 events $8.60 -8K -$69K 0 Sep 16, 2025 Sep 18, 2025
Rossi Michael J. · Director, Officer 9 operations -1.3M
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Rossi Michael J. Director, Officer 9 operations -1.3M 0 Sep 16, 2025 Sep 18, 2025
Wilms Joris · Officer Other Form 4 events -$110K
Price $8.60 Qty -13K Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Wilms Joris Officer Other Form 4 events $8.60 -13K -$110K 0 Sep 16, 2025 Sep 18, 2025
Wilms Joris · Officer 12 operations -338K
Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Wilms Joris Officer 12 operations -338K 0 Sep 16, 2025 Sep 18, 2025
Wedell-Wedellsborg Johan · Director, 10% Owner 2 operations -$39M
Price $8.60 Qty -4.6M Owned 0 Trade date Sep 16, 2025 Filed date Sep 18, 2025
Wedell-Wedellsborg Johan Director, 10% Owner 2 operations $8.60 -4.6M -$39M 0 Sep 16, 2025 Sep 18, 2025
15 of 19
15 of 19 Sign in to continue to older insider transactions.

Y-mAbs Therapeutics, Inc. (YMAB) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Wg Biotech Aps 4.6M
% of shares outstanding 10.4% Filing date Feb 14, 2024
Wg Biotech Aps 4.6M 10.4% Feb 14, 2024
BlackRock Inc. 2.9M
% of shares outstanding 6.7% Filing date Jan 26, 2024
BlackRock Inc. 2.9M 6.7% Jan 26, 2024
Sofinnova Venture Partners X, L.P. 2.2M
% of shares outstanding 5.0% Filing date Feb 15, 2022
Sofinnova Venture Partners X, L.P. 2.2M 5.0% Feb 15, 2022
Vanguard Group Inc 2.0M
% of shares outstanding 4.6% Filing date Nov 12, 2024
Vanguard Group Inc 2.0M 4.6% Nov 12, 2024
Wellington Management Group LLP 1.9M
% of shares outstanding 4.4% Filing date Apr 11, 2022
Wellington Management Group LLP 1.9M 4.4% Apr 11, 2022
Acorn Bioventures, L.P. 1.2M
% of shares outstanding 2.7% Filing date Feb 6, 2024
Acorn Bioventures, L.P. 1.2M 2.7% Feb 6, 2024
Paradigm Biocapital Advisors LP 0
% of shares outstanding 0.0% Filing date Nov 14, 2025
Paradigm Biocapital Advisors LP 0 0.0% Nov 14, 2025
Hbm Healthcare Investments (cayman) Ltd. 0
% of shares outstanding 0.0% Filing date Nov 14, 2025
Hbm Healthcare Investments (cayman) Ltd. 0 0.0% Nov 14, 2025
8 of 11

Y-mAbs Therapeutics, Inc. (YMAB) ownership FAQ

Who owns YMAB?

3 reporting institutions disclosed YMAB position changes in the Q4 2025 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2025.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.